TSC22 domain family member 3 (TSC22D3; GILZ); v-rel reticuloendotheliosis viral oncogene homolog A (RELA; p65) BriefCommunication Pages: 1138 - 1138
Aryl hydrocarbon receptor (AHR); kynurenine; tryptophan 2,3-dioxygenase (TDO2; TDO) BriefCommunication Pages: 1139 - 1139
Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (APOBEC3G) BriefCommunication Pages: 1140 - 1140
Microphthalmia-associated transcription factor (MITF); hypoxia-inducible factor 1 (HIF1) BriefCommunication Pages: 1141 - 1141
FYVE, RhoGEF and PH domain containing 1 (FGD1); mitogen-activated protein kinase kinase kinase 11 (MAP3K11; MLK3) BriefCommunication Pages: 1149 - 1149
Prostaglandin E2 receptor EP4 subtype (prostanoid EP4 receptor; PTGER4) BriefCommunication Pages: 1153 - 1153
Proteomic method to identify heat shock protein 90 (Hsp90)-interacting proteins as new therapeutic targets BriefCommunication Pages: 1157 - 1157
Fluoro hexitol nucleic acid–modified antisense oligonucleotide therapeutics BriefCommunication Pages: 1158 - 1158
Population-specific expression analysis (PSEA) for biomarker identification BriefCommunication Pages: 1159 - 1159
Lipid nanoparticle formulations for spleen-specific delivery of small interfering RNA to macrophages and dendritic cells (DCs) BriefCommunication Pages: 1162 - 1162
Engineered biosynthesis of new kanamycin analogs and intermediates BriefCommunication Pages: 1163 - 1163
Truncated neurokinin 1 substance P receptor (TACR1) as a marker for colorectal cancer BriefCommunication Pages: 1164 - 1164